Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05087979 · ClinicalTrials.gov registry record · NA

Use of Stable Airway Management Device in Monitored Anesthesia Care

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05087979: Completed NA study, sponsored by Virginia Commonwealth University.

NCT05087979 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05087979, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The aim of this study is to determine if the Stable Airway Management device (SAM) is safe in maintaining the airway in a stable, non-obstructing position during anesthetic cases requiring monitored anesthesia care (MAC).

Primary Outcome

total number of apneic events greater than 20 seconds per 15-minute intervals, requiring airway manipulation - The median value of airway manipulations will be reported for each arm, along with the range of manipulations (low-high) for each study arm will be reported.

Interventions

  • DEVICE Stable airway management (SAM) device

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-07-28
Est. Completion 2022-09-29
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT05087979 record still lists

NCT05087979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Stable airway management (SAM) device is the first listed.

NCT05087979 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05087979 about?

NCT05087979 is a clinical study titled "Use of Stable Airway Management Device in Monitored Anesthesia Care". The aim of this study is to determine if the Stable Airway Management device (SAM) is safe in maintaining the airway in a stable, non-obstructing position during anesthetic cases requiring monitored anesthesia care (MAC).

What is the current status of trial NCT05087979?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-07-28. Estimated completion is 2022-09-29.

What interventions are being tested in trial NCT05087979?

The interventions under investigation include: Stable airway management (SAM) device (DEVICE).

Who is sponsoring clinical trial NCT05087979?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05087979's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05087979, the US trial registry maintained by the National Library of Medicine. NCT05087979 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.